Literature DB >> 1314025

Filaments of Lewy bodies contain insoluble cytoskeletal elements.

P G Galloway1, P Mulvihill, G Perry.   

Abstract

The Lewy body is an intraneuronal inclusion body that is one of the histologic hallmarks of Parkinson's disease, a degenerative disease of the brain. Ultrastructural analysis has shown that the Lewy body is composed of straight 7-20 nm filaments and amorphous elements. Previous light microscopic, immunocytochemical studies have suggested the presence of neurofilament, microtubule, ubiquitin, and paired helical filament-related epitopes in Lewy bodies. Yet the biochemical composition of the Lewy body remains incompletely elucidated. The ultrastructural and immunocytochemical similarities and differences between the Lewy body and the neurofibrillary tangle of Alzheimer's disease raise questions as to their relation to each other and possible shared mechanisms of formation. In this study the authors examine whether ultrastructural immunocytochemical analysis of Lewy bodies confirms the light microscopic data, whether the structures and epitopes of Lewy bodies share with Alzheimer's disease neurofibrillary tangles the property of insolubility in sodium dodecyl sulfate, and speculate about the subunit composition of Lewy body filaments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314025      PMCID: PMC1886359     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Hirano body filaments contain actin and actin-associated proteins.

Authors:  P G Galloway; G Perry; P Gambetti
Journal:  J Neuropathol Exp Neurol       Date:  1987-03       Impact factor: 3.685

2.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Authors:  I Grundke-Iqbal; K Iqbal; M Quinlan; Y C Tung; M S Zaidi; H M Wisniewski
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

3.  Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

Authors:  G Perry; R Friedman; G Shaw; V Chau
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.

Authors:  J Kahn; B H Anderton; W R Gibb; A J Lees; F R Wells; C D Marsden
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

5.  Immunocytochemical properties of Alzheimer straight filaments.

Authors:  G Perry; P Mulvihill; V Manetto; L Autilio-Gambetti; P Gambetti
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

6.  Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy.

Authors:  P G Galloway
Journal:  Neurosci Lett       Date:  1988-08-31       Impact factor: 3.046

7.  Filaments of Pick's bodies contain altered cytoskeletal elements.

Authors:  G Perry; D Stewart; R Friedman; V Manetto; L Autilio-Gambetti; P Gambetti
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

8.  Aberrant neurofilament phosphorylation in Alzheimer disease.

Authors:  N H Sternberger; L A Sternberger; J Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases.

Authors:  V Manetto; G Perry; M Tabaton; P Mulvihill; V A Fried; H T Smith; P Gambetti; L Autilio-Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Influence of neuronal location on antigenic properties of neurofibrillary tangles.

Authors:  M Tabaton; G Perry; L Autilio-Gambetti; V Manetto; P Gambetti
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

View more
  33 in total

1.  LRRK2 function on actin and microtubule dynamics in Parkinson disease.

Authors:  Loukia Parisiadou; Huaibin Cai
Journal:  Commun Integr Biol       Date:  2010-09

2.  The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.

Authors:  Payal N Gandhi; Xinglong Wang; Xiongwei Zhu; Shu G Chen; Amy L Wilson-Delfosse
Journal:  J Neurosci Res       Date:  2008-06       Impact factor: 4.164

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Mallory body filaments become insoluble after normal assembly into intermediate filaments.

Authors:  M S Pollanen; P Markiewicz; L Weyer; M C Goh; C Bergeron
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

5.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.

Authors:  T Iwatsubo; H Yamaguchi; M Fujimuro; H Yokosawa; Y Ihara; J Q Trojanowski; V M Lee
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

8.  N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.

Authors:  Rosalia Crupi; Daniela Impellizzeri; Marika Cordaro; Rosalba Siracusa; Giovanna Casili; Maurizio Evangelista; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-03-19       Impact factor: 5.590

Review 9.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  A neurotoxic phosphoform of Elk-1 associates with inclusions from multiple neurodegenerative diseases.

Authors:  Anup Sharma; Linda M Callahan; Jai-Yoon Sul; Tae Kyung Kim; Lindy Barrett; Minsun Kim; James M Powers; Howard Federoff; James Eberwine
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.